Rapid and sensitive assay of K-ras mutations in pancreatic cancer by electrochemical detection with ferrocenyl-naphthalene-diimide

Nami Ishikawa, Takahito Miya, Kazuhiro Mizumoto, Kenoki Ohuchida, Eishi Nagai, Koji Yamaguchi, Masahiko Amano, Shigeori Takenaka, Masao Tanaka

Research output: Contribution to journalArticle

Abstract

The DNA chip is a very powerful tool for genetic analysis. Conventional DNA chips that utilize fluorescence detection systems are very complicated, expensive and impractical, but the electrochemical array (ECA) chip is gaining popularity. To investigate the validity of the ECA chip, which utilizes ferrocenyl-naphthalene-diimide (FND), k-ras mutations in 20 pancreatic cancer tissues were examined. DNA was isolated from 20 pancreatic cancer tissues and subjected to a 2-stage polymerase chain reaction (PCR). The k-ras mutations were detected with the ECA chip. To verify the reliability of the ECA chip, the DNA was also analyzed by direct sequencing and the PCR-dependent preferential homoduplex formation assay (PCR-PHFA). The ECA chip could detect one mutation in a background of 1000 wild-type DNAs. K-ras mutations were identified in 17 out of 20 (85%) pancreatic cancer samples. Three mutations of codon 12 of k-ras, GTT, GAT and AGT, were detected. K-ras mutations were detected in 13 out of 20 (65%) samples by sequencing and in 17 out of 20 (85%) samples by PCR-PHFA. These findings were concordant with the ECA chip result. The FND-ECA chip is a sensitive, rapid and reliable method for screening point mutations in a variety of clinical samples.

Original languageEnglish
Pages (from-to)47-54
Number of pages8
JournalCancer Genomics and Proteomics
Volume3
Issue number1
Publication statusPublished - Jan 1 2006

Fingerprint

Pancreatic Neoplasms
Assays
Polymerase chain reaction
Oligonucleotide Array Sequence Analysis
Mutation
DNA
Polymerase Chain Reaction
Tissue
Screening
Point Mutation
Codon
Fluorescence
naphthalenediimide

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Rapid and sensitive assay of K-ras mutations in pancreatic cancer by electrochemical detection with ferrocenyl-naphthalene-diimide. / Ishikawa, Nami; Miya, Takahito; Mizumoto, Kazuhiro; Ohuchida, Kenoki; Nagai, Eishi; Yamaguchi, Koji; Amano, Masahiko; Takenaka, Shigeori; Tanaka, Masao.

In: Cancer Genomics and Proteomics, Vol. 3, No. 1, 01.01.2006, p. 47-54.

Research output: Contribution to journalArticle

Ishikawa, Nami ; Miya, Takahito ; Mizumoto, Kazuhiro ; Ohuchida, Kenoki ; Nagai, Eishi ; Yamaguchi, Koji ; Amano, Masahiko ; Takenaka, Shigeori ; Tanaka, Masao. / Rapid and sensitive assay of K-ras mutations in pancreatic cancer by electrochemical detection with ferrocenyl-naphthalene-diimide. In: Cancer Genomics and Proteomics. 2006 ; Vol. 3, No. 1. pp. 47-54.
@article{edf988a5f17348c5ae7cedf787d0773b,
title = "Rapid and sensitive assay of K-ras mutations in pancreatic cancer by electrochemical detection with ferrocenyl-naphthalene-diimide",
abstract = "The DNA chip is a very powerful tool for genetic analysis. Conventional DNA chips that utilize fluorescence detection systems are very complicated, expensive and impractical, but the electrochemical array (ECA) chip is gaining popularity. To investigate the validity of the ECA chip, which utilizes ferrocenyl-naphthalene-diimide (FND), k-ras mutations in 20 pancreatic cancer tissues were examined. DNA was isolated from 20 pancreatic cancer tissues and subjected to a 2-stage polymerase chain reaction (PCR). The k-ras mutations were detected with the ECA chip. To verify the reliability of the ECA chip, the DNA was also analyzed by direct sequencing and the PCR-dependent preferential homoduplex formation assay (PCR-PHFA). The ECA chip could detect one mutation in a background of 1000 wild-type DNAs. K-ras mutations were identified in 17 out of 20 (85{\%}) pancreatic cancer samples. Three mutations of codon 12 of k-ras, GTT, GAT and AGT, were detected. K-ras mutations were detected in 13 out of 20 (65{\%}) samples by sequencing and in 17 out of 20 (85{\%}) samples by PCR-PHFA. These findings were concordant with the ECA chip result. The FND-ECA chip is a sensitive, rapid and reliable method for screening point mutations in a variety of clinical samples.",
author = "Nami Ishikawa and Takahito Miya and Kazuhiro Mizumoto and Kenoki Ohuchida and Eishi Nagai and Koji Yamaguchi and Masahiko Amano and Shigeori Takenaka and Masao Tanaka",
year = "2006",
month = "1",
day = "1",
language = "English",
volume = "3",
pages = "47--54",
journal = "Cancer Genomics and Proteomics",
issn = "1109-6535",
publisher = "International Institute of Anticancer Research",
number = "1",

}

TY - JOUR

T1 - Rapid and sensitive assay of K-ras mutations in pancreatic cancer by electrochemical detection with ferrocenyl-naphthalene-diimide

AU - Ishikawa, Nami

AU - Miya, Takahito

AU - Mizumoto, Kazuhiro

AU - Ohuchida, Kenoki

AU - Nagai, Eishi

AU - Yamaguchi, Koji

AU - Amano, Masahiko

AU - Takenaka, Shigeori

AU - Tanaka, Masao

PY - 2006/1/1

Y1 - 2006/1/1

N2 - The DNA chip is a very powerful tool for genetic analysis. Conventional DNA chips that utilize fluorescence detection systems are very complicated, expensive and impractical, but the electrochemical array (ECA) chip is gaining popularity. To investigate the validity of the ECA chip, which utilizes ferrocenyl-naphthalene-diimide (FND), k-ras mutations in 20 pancreatic cancer tissues were examined. DNA was isolated from 20 pancreatic cancer tissues and subjected to a 2-stage polymerase chain reaction (PCR). The k-ras mutations were detected with the ECA chip. To verify the reliability of the ECA chip, the DNA was also analyzed by direct sequencing and the PCR-dependent preferential homoduplex formation assay (PCR-PHFA). The ECA chip could detect one mutation in a background of 1000 wild-type DNAs. K-ras mutations were identified in 17 out of 20 (85%) pancreatic cancer samples. Three mutations of codon 12 of k-ras, GTT, GAT and AGT, were detected. K-ras mutations were detected in 13 out of 20 (65%) samples by sequencing and in 17 out of 20 (85%) samples by PCR-PHFA. These findings were concordant with the ECA chip result. The FND-ECA chip is a sensitive, rapid and reliable method for screening point mutations in a variety of clinical samples.

AB - The DNA chip is a very powerful tool for genetic analysis. Conventional DNA chips that utilize fluorescence detection systems are very complicated, expensive and impractical, but the electrochemical array (ECA) chip is gaining popularity. To investigate the validity of the ECA chip, which utilizes ferrocenyl-naphthalene-diimide (FND), k-ras mutations in 20 pancreatic cancer tissues were examined. DNA was isolated from 20 pancreatic cancer tissues and subjected to a 2-stage polymerase chain reaction (PCR). The k-ras mutations were detected with the ECA chip. To verify the reliability of the ECA chip, the DNA was also analyzed by direct sequencing and the PCR-dependent preferential homoduplex formation assay (PCR-PHFA). The ECA chip could detect one mutation in a background of 1000 wild-type DNAs. K-ras mutations were identified in 17 out of 20 (85%) pancreatic cancer samples. Three mutations of codon 12 of k-ras, GTT, GAT and AGT, were detected. K-ras mutations were detected in 13 out of 20 (65%) samples by sequencing and in 17 out of 20 (85%) samples by PCR-PHFA. These findings were concordant with the ECA chip result. The FND-ECA chip is a sensitive, rapid and reliable method for screening point mutations in a variety of clinical samples.

UR - http://www.scopus.com/inward/record.url?scp=33144454472&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33144454472&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33144454472

VL - 3

SP - 47

EP - 54

JO - Cancer Genomics and Proteomics

JF - Cancer Genomics and Proteomics

SN - 1109-6535

IS - 1

ER -